The genome-wide mutational consequences of DNA hypomethylation

DNA methylation is important for establishing and maintaining cell identity and for genomic stability. This is achieved by regulating the accessibility of regulatory and transcriptional elements and the compaction of subtelomeric, centromeric, and other inactive genomic regions. Carcinogenesis is accompanied by a global loss in DNA methylation, which facilitates the transformation of cells. Cancer hypomethylation may also cause genomic instability, for example through interference with the protective function of telomeres and centromeres. However, understanding the role(s) of hypomethylation in tumor evolution is incomplete because the precise mutational consequences of global hypomethylation have thus far not been systematically assessed. Here we made genome-wide inventories of all possible genetic variation that accumulates in single cells upon the long-term global hypomethylation by CRISPR/CAS9-mediated conditional knockdown of DNMT1. Depletion of DNMT1 results in a genomewide reduction in DNA methylation levels. Hypomethylated cells show reduced proliferation rates, reactivation of the inactive X-chromosome and abnormal nuclear morphologies. Prolonged hypomethylation is accompanied by increased chromosomal instability. However, there is no increase in mutational burden, enrichment for certain mutational signatures or structural changes to the genome. We conclude that the primary consequence of global hypomethylation is chromosomal instability and does not necessarily lead to other small-scale or structural mutational effects.

[1]  S. Nik-Zainal,et al.  Substitution mutational signatures in whole-genome–sequenced cancers in the UK population , 2022, Science.

[2]  E. Cuppen,et al.  Precancerous liver diseases do not cause increased mutagenesis in liver stem cells , 2021, Communications Biology.

[3]  E. Cuppen,et al.  MutationalPatterns: the one stop shop for the analysis of mutational processes , 2021, bioRxiv.

[4]  A. Straight,et al.  AlphaHOR-RES: a method for enriching centromeric DNA v1 , 2021 .

[5]  V. Barra,et al.  Losing DNA methylation at repetitive elements and breaking bad , 2021, Epigenetics & chromatin.

[6]  Aaron M. Streets,et al.  The complete sequence of a human genome , 2021, bioRxiv.

[7]  Jose Espejo Valle-Inclan,et al.  GRIDSS2: comprehensive characterisation of somatic structural variation using single breakend variants and structural variant phasing , 2021, Genome Biology.

[8]  David T. W. Jones,et al.  Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition , 2020, Nature Genetics.

[9]  Nuno A. Fonseca,et al.  Patterns of somatic structural variation in human cancer genomes , 2020, Nature.

[10]  Runan Yao,et al.  ShinyGO: a graphical gene-set enrichment tool for animals and plants , 2019, Bioinform..

[11]  Huimin Shen,et al.  Increased expression of TET3 predicts unfavorable prognosis in patients with ovarian cancer-a bioinformatics integrative analysis , 2019, Journal of Ovarian Research.

[12]  A. Aguilera,et al.  R Loops: From Physiological to Pathological Roles , 2019, Cell.

[13]  David A Eccles Creating Differential Transcript Expression Results with DESeq2 v1 , 2019, protocols.io.

[14]  Jose Espejo Valle-Inclan,et al.  GRIDSS, PURPLE, LINX: Unscrambling the tumor genome via integrated analysis of structural variation and copy number , 2019, bioRxiv.

[15]  Nicholas A. Rossi,et al.  Inference of CRISPR Edits from Sanger Trace Data , 2019, bioRxiv.

[16]  S. Malek,et al.  The Genomic Landscape of Centromeres in Cancers , 2019, Scientific Reports.

[17]  A. Scelfo,et al.  Keeping the Centromere under Control: A Promising Role for DNA Methylation , 2019, Cells.

[18]  A. Meissner,et al.  Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors , 2019, Nature Communications.

[19]  E. Cuppen,et al.  5-Fluorouracil treatment induces characteristic T>G mutations in human cancer , 2019, Nature Communications.

[20]  J. S. Pedersen,et al.  Deficiency of nucleotide excision repair is associated with mutational signature observed in cancer , 2019, Genome research.

[21]  E. Cuppen,et al.  Early divergence of mutational processes in human fetal tissues , 2019, Science Advances.

[22]  Thomas Lengauer,et al.  RnBeads 2.0: comprehensive analysis of DNA methylation data , 2019, Genome Biology.

[23]  Ville Mustonen,et al.  The repertoire of mutational signatures in human cancer , 2018, Nature.

[24]  E. Cuppen,et al.  The mutational impact of culturing human pluripotent and adult stem cells , 2018, Nature Communications.

[25]  S. Sleijfer,et al.  Pan-cancer whole-genome analyses of metastatic solid tumours , 2018, bioRxiv.

[26]  Edwin Cuppen,et al.  MutationalPatterns: comprehensive genome-wide analysis of mutational processes , 2016, Genome Medicine.

[27]  S. Nik-Zainal,et al.  Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer , 2017, Science.

[28]  Hemali P. Phatnani,et al.  Evaluating Synthetic Activation and Repression of Neuropsychiatric-Related Genes in hiPSC-Derived NPCs, Neurons, and Astrocytes , 2017, Stem cell reports.

[29]  M. Goodell,et al.  DNMT3A in Leukemia. , 2017, Cold Spring Harbor perspectives in medicine.

[30]  Xing-Ming Zhao,et al.  OGEE v2: an update of the online gene essentiality database with special focus on differentially essential genes in human cancer cell lines , 2016, Nucleic Acids Res..

[31]  Hans Clevers,et al.  Tissue-specific mutation accumulation in human adult stem cells during life , 2016, Nature.

[32]  Max A. Horlbeck,et al.  Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation , 2016, eLife.

[33]  J. Shay,et al.  Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies , 2016, Genome Medicine.

[34]  Victor Guryev,et al.  Single-cell sequencing reveals karyotype heterogeneity in murine and human malignancies , 2016, Genome Biology.

[35]  K. Kaestner,et al.  DNA Hypomethylation Contributes to Genomic Instability and Intestinal Cancer Initiation , 2016, Cancer Prevention Research.

[36]  A. Di Leonardo,et al.  DNA demethylation caused by 5-Aza-2′-deoxycytidine induces mitotic alterations and aneuploidy , 2016, Oncotarget.

[37]  D. Durocher,et al.  High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities , 2015, Cell.

[38]  Matthew Meyerson,et al.  CHROMOTHRIPSIS FROM DNA DAMAGE IN MICRONUCLEI , 2015, Nature.

[39]  Feng Zhang,et al.  Genome engineering using CRISPR-Cas9 system. , 2015, Methods in molecular biology.

[40]  Jérôme Déjardin,et al.  Constitutive heterochromatin formation and transcription in mammals , 2014, Epigenetics & Chromatin.

[41]  Winston Timp,et al.  Large hypomethylated blocks as a universal defining epigenetic alteration in human solid tumors , 2014, Genome Medicine.

[42]  Neville E. Sanjana,et al.  Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.

[43]  B. Bernstein,et al.  Epigenetic Reprogramming in Cancer , 2013, Science.

[44]  J. Wong,et al.  UHRF1 targets DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated H3K9 , 2013, Nature Communications.

[45]  Howard Cedar,et al.  DNA methylation dynamics in health and disease , 2013, Nature Structural &Molecular Biology.

[46]  W. Kaelin,et al.  Use and Abuse of RNAi to Study Mammalian Gene Function , 2012, Science.

[47]  G. Vance,et al.  Cancer-associated alteration of pericentromeric heterochromatin may contribute to chromosome instability , 2012, Oncogene.

[48]  Wendy S. W. Wong,et al.  Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..

[49]  J. Vijg,et al.  5-Aza-2′-deoxycytidine-induced genome rearrangements are mediated by DNMT1 , 2012, Oncogene.

[50]  P. Laird,et al.  Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina–associated domains , 2011, Nature Genetics.

[51]  Bypass of cell cycle arrest induced by transient DNMT1 post-transcriptional silencing triggers aneuploidy in human cells , 2012, Cell Division.

[52]  C. Cole,et al.  COSMIC: the catalogue of somatic mutations in cancer , 2011, Genome Biology.

[53]  M. Esteller,et al.  DNMT3B gene amplification predicts resistance to DNA demethylating drugs , 2011, Genes, chromosomes & cancer.

[54]  W. Reik,et al.  Epigenetic Reprogramming in Plant and Animal Development , 2010, Science.

[55]  A. Hagemeijer,et al.  Acquired mutations in TET2 are common in myelodysplastic syndromes , 2009, Nature Genetics.

[56]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[57]  D. Schübeler,et al.  Genetics and epigenetics: stability and plasticity during cellular differentiation. , 2009, Trends in genetics : TIG.

[58]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[59]  E. Li,et al.  Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells , 2007, Nature Genetics.

[60]  C. Allis,et al.  Epigenetics: A Landscape Takes Shape , 2007, Cell.

[61]  Jing Chen,et al.  Expression of human DNA methyltransferase 1 in colorectal cancer tissues and their corresponding distant normal tissues , 2007, International Journal of Colorectal Disease.

[62]  M. Fraga,et al.  DNA methyltransferases control telomere length and telomere recombination in mammalian cells , 2006, Nature Cell Biology.

[63]  S. Matsui,et al.  Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. , 2005, Cancer research.

[64]  N. Eberhardt,et al.  Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers. , 2005, Gynecologic oncology.

[65]  Li Yang,et al.  Expression of Dnmt1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer. , 2004, World journal of gastroenterology.

[66]  C. Shen,et al.  DNA methyltransferase Dnmt1 and mismatch repair , 2004, Oncogene.

[67]  R. Jaenisch,et al.  Chromosomal Instability and Tumors Promoted by DNA Hypomethylation , 2003, Science.

[68]  R. Jaenisch,et al.  Induction of Tumors in Mice by Genomic Hypomethylation , 2003, Science.

[69]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[70]  W. Lau,et al.  Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. , 2001, The American journal of pathology.

[71]  M. Ehrlich,et al.  Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. , 1999, Cancer genetics and cytogenetics.

[72]  Rudolf Jaenisch,et al.  DNA hypomethylation leads to elevated mutation rates , 1998, Nature.

[73]  D. Santi,et al.  Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine. , 1984, Proceedings of the National Academy of Sciences of the United States of America.